Clobetasol propionate    (DrugBank: Clobetasol propionate, Clobetasol)

2 diseases
IDDisease name (Link within this page)Number of trials
46Malignant rheumatoid arthritis1
162Pemphigoid3

46. Malignant rheumatoid arthritis    [ 4,183 clinical trials,   2,538 drugs,   (DrugBank: 401 drugs),   183 drug target genes,   219 drug target pathways]
Searched query = "Malignant rheumatoid arthritis", "Rheumatoid arthritis", "Rheumatoid arthritis with vasculitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 4,183 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04649697
(ClinicalTrials.gov)
December 1, 202026/10/2020Rebamipide (Regular & Nanoparticulated) vs. Clobetasol in Management of Methotrexate-Induced Oral Ulceration in Rheumatoid Arthritis PatientsEvaluation of Topical Rebamipide Versus Topical Clobetasol in Management of Methotrexate-Induced Oral Ulceration in Rheumatoid Arthritis Patients: Randomized-Controlled Clinical TrialRheumatoid ArthritisDrug: Rebamipide;Drug: Nanoparticulated Rebamipide;Drug: Clobetasol PropionateCairo UniversityNULLNot yet recruiting20 Years70 YearsAll39Phase 3NULL

162. Pemphigoid    [ 70 clinical trials,   117 drugs,   (DrugBank: 46 drugs),   30 drug target genes,   128 drug target pathways]
Searched query = "Pemphigoid", "Epidermolysis bullosa acquisita"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
3 / 70 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03926377
(ClinicalTrials.gov)
April 201915/4/2019Influence of Dermocorticoids on Bone Mineral Density in Patients With Bullous PemphigoidInfluence of Dermocorticoids on Bone Mineral Density in Patients With Bullous PemphigoidOsteoporosis;Bullous PemphigoidProcedure: bone densitometry;Biological: blood test;Procedure: radiographs of the thoracic and lumbar spine;Procedure: Clobetasol propionateCentre Hospitalier Universitaire, AmiensUniversity Hospital, RouenNot yet recruiting18 YearsN/AAll50Phase 4NULL
2NCT02360202
(ClinicalTrials.gov)
April 20157/1/2015Evaluation of Fluid Retention Due to Superpotent Topical CorticosteroidEvaluation of Fluid Retention Due to Superpotent Topical Corticosteroid in Patients With Bullous PemphigoidBullous PemphigoidProcedure: Impedance analysis;Drug: Clobetasol Propionate cream treatmentUniversity Hospital, RouenSociété de Dermatologie FrançaiseRecruiting18 YearsN/AAll35Phase 4France
3NCT02313870
(ClinicalTrials.gov)
January 20088/12/2014Topical Steroids Alone or Associated With Methotrexate in Bullous PemphigoidComparison of Monotherapy With Protracted Superpotent Topical Steroids to Superpotent Topical Steroids Associated With Methotrexate in Bullous PemphigoidBullous PemphigoidDrug: clobetasol propionate + Methotrexate;Drug: clobetasol propionate aloneUniversity Hospital, MontpellierNULLRecruiting18 YearsN/ABoth300Phase 3France